The discovery of CB receptors (1988) and endogenous molecules which activate these receptors (1992) resulted in the invention from the endocannabinoid process. Pharmacological modulation on the endogenous cannabinoid program provides new therapeutic alternatives of remedy of numerous diseases and signs such as the GIT Diseases, which includes of na… Read More